CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer Inc. and BioNTech SE in the US, which will see CureVac’s former collaborator GSK Plc receive as much as $500 million and 1% of royalties from future vaccine sales.
www.bloomberg.com
#GSK #Set #Million #Payment #mRNA #Lawsuit #Settlement
Get caught up. www.bloomberg.com #Indias #Russian #Oil #Flow #Expected #Dry #UpAfter #Sanctions Related reading:Canada Pitches Bank Expansion in China, Seeking…
As pictures of queues outside gold stores flooded social media over the past month, professional precious metals traders were getting…
Get caught up. www.bloomberg.com #Iran #Indirect #Talks #Positive #Note Related reading:Canada Pitches Bank Expansion in China, Seeking to Grow ExportsTrump…
